How Ligachem Biosciences Is Reshaping the Global K-Bio Landscape
Most Western investors miss Korea’s quiet dominance in critical K-Bio sectors. Ligachem Biosciences isn’t just competing; it’s setting new global standards for
Biotech
Alteogen’s Hybrozyme: K-Bio Policy Driving Global Reach
South Korea’s policies boost Alteogen’s global market expansion and shape the Korean biotech trade strategy for advanced biologics.
Matica Biotechnology and Cha Biotech: Leading the Future of Cell and Gene Therapy
[su_heading size=”27″ align=”left” margin=”40″]Growth and Opportunities in the Global Biotech Industry[/su_heading] The biotech industry has seen rapid growth in recent years, with the cell and gene therapy (CGT) market drawing significant attention. Paul Kim, CEO of Matica Biotechnology, announced plans to build a second plant in Texas with a 2000-liter capacity to address the growing … Read more